Literature DB >> 11592357

Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?

W H Robinson1, M C Genovese, L W Moreland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592357     DOI: 10.1002/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  77 in total

1.  Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis.

Authors:  Zahra Ahmed; Robert Powell; Gareth Llewelyn; Alex Anstey
Journal:  BMJ Case Rep       Date:  2011-12-01

2.  Neurological complications of biologic therapy in psoriasis: a review.

Authors:  Mark Bechtel; Catherine Sanders; Ann Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

Review 3.  [Biologics. New drugs, new adverse reactions].

Authors:  J C Prinz
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

4.  [Tumour necrosis factor receptor-associated periodic syndrome. A rare differential diagnosis of multiple sclerosis].

Authors:  P Günther; K Minden; W Hermann; J-P Schneider; A Wagner
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

Review 5.  Anti-tumor necrosis factor alpha-associated multiple sclerosis.

Authors:  David S Titelbaum; Alexandra Degenhardt; R Philip Kinkel
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

6.  Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors:  Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

7.  New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.

Authors:  Makoto Tanno; Ichiro Nakamura; Shunsuke Kobayashi; Kumiko Kurihara; Katsumi Ito
Journal:  Clin Rheumatol       Date:  2006-11       Impact factor: 2.980

Review 8.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

9.  Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2005-09-15       Impact factor: 7.376

Review 10.  The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis.

Authors:  Aksel Siva; Sabahattin Saip
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.